Browsing: Around

Although Viking TherapeuticsVKTX isn’t officially on the auction block, investors are increasingly viewing it as a potential acquisition target. This perception stems from the company’s rapidly expanding obesity franchise, driven by the late-stage development of VK2735, the addition of a new obesity candidate and an upcoming clinical data readout that could further bolster investor confidence

Good Day Oklahoma’s, Chloe Boudames, sits down with Dr. Kesinger of Integris to talk about the Medicare GLP-1 Bridge Program